Winning Health Technology Group Co., Ltd. (SHE:300253)
China flag China · Delayed Price · Currency is CNY
6.41
-0.36 (-5.32%)
Oct 30, 2026, 3:04 PM CST

SHE:300253 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,5181,7621,3361,1141,2821,601
Trading Asset Securities
--3---
Cash & Short-Term Investments
1,5181,7621,3391,1141,2821,601
Cash Growth
23.97%31.60%20.18%-13.07%-19.92%56.06%
Accounts Receivable
2,7222,8723,3793,3422,6932,215
Other Receivables
92.5399.43131.88158.13135.25151.35
Receivables
2,8142,9723,5113,5002,8292,366
Inventory
110.21100.3111.11110.7497.5133.09
Prepaid Expenses
-2.421.122.121.021.18
Other Current Assets
79.7488.55132.85126.7102.7374.16
Total Current Assets
4,5224,9255,0954,8544,3124,175
Property, Plant & Equipment
472.15479.18492.9508.88528.86540.99
Long-Term Investments
848.16870.87898.69946.76960.56993.46
Goodwill
409.9409.9497.59589.62596.23637.95
Other Intangible Assets
1,2871,4471,1061,037505.43940.32
Long-Term Accounts Receivable
13.112.8717.5621.8229.5718.38
Long-Term Deferred Tax Assets
324.9268.44193.18214.34205.47177.19
Long-Term Deferred Charges
244.27109.96455.74377.01684.0313.12
Total Assets
8,1228,5238,7568,5497,8227,496

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
655.11672.67697.53674.69602.97499.25
Accrued Expenses
27.58363.98425.47480.9400.78286.33
Short-Term Debt
6.4415.0640.2958.0342.86-
Current Portion of Long-Term Debt
-13.8811.577.733.872.26
Current Portion of Leases
-8.3313.5612.8715.0513.83
Current Income Taxes Payable
228.367.916.465.1257.2155.03
Current Unearned Revenue
223.24270.65141.3144.68194.26202.83
Other Current Liabilities
1,445387.19299.45263.74265.42214.24
Total Current Liabilities
2,5861,7401,6461,7081,5821,274
Long-Term Debt
-1,1021,0521,002950.5898.24
Long-Term Leases
17.3411.5713.7617.6224.222.15
Long-Term Unearned Revenue
0.981.541.351.742.32.29
Long-Term Deferred Tax Liabilities
38.7338.7339.0739.0670.8373.47
Other Long-Term Liabilities
29.5834.5671.1599.6464.7352.97
Total Liabilities
2,6732,9282,8232,8682,6952,323

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
2,2012,2162,1912,1522,1482,146
Additional Paid-In Capital
1,1031,0811,063871.65635.69572.22
Retained Earnings
2,0782,3192,7262,6812,3442,278
Treasury Stock
-6.33-120.64-120.64-120.64-120.64-
Comprehensive Income & Other
91.791.7102.91102.91102.92102.93
Total Common Equity
5,4685,5865,9625,6875,1105,100
Minority Interest
-19.669.19-27.95-5.8116.8473.46
Shareholders' Equity
5,4495,5965,9345,6815,1275,173
Total Liabilities & Equity
8,1228,5238,7568,5497,8227,496

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
23.781,1501,1311,0981,036936.48
Net Cash (Debt)
1,494611.59207.8315.99245.18664.07
Net Cash Growth
1228.88%194.27%1199.84%-93.48%-63.08%-18.20%
Net Cash Per Share
0.680.280.100.010.110.31
Filing Date Shares Outstanding
2,2002,2012,1982,1452,1332,146
Total Common Shares Outstanding
2,2002,2012,1772,1382,1332,146
Working Capital
1,9363,1853,4503,1462,7292,901
Book Value Per Share
2.492.542.742.662.402.38
Tangible Book Value
3,7713,7294,3594,0614,0083,522
Tangible Book Value Per Share
1.711.692.001.901.881.64
Buildings
-517.82517.82517.82517.03517.03
Machinery
-73.969.2966.0360.758.44
Construction In Progress
-----1.29